JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M202513200 on April 10, 2002

J. Biol. Chem., Vol. 277, Issue 25, 22421-22425, June 21, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/25/22421    most recent
M202513200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taoka, S.
Right arrow Articles by Banerjee, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taoka, S.
Right arrow Articles by Banerjee, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Stopped-flow Kinetic Analysis of the Reaction Catalyzed by the Full-length Yeast Cystathionine beta -Synthase*

Shinichi Taoka and Ruma BanerjeeDagger

From the Biochemistry Department, University of Nebraska, Lincoln, Nebraska 68588-0664

Received for publication, March 14, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cystathionine beta -synthase found in yeast catalyzes a pyridoxal phosphate-dependent condensation of homocysteine and serine to form cystathionine. Unlike the homologous mammalian enzymes, yeast cystathionine beta -synthase lacks a second cofactor, heme, which facilitates detailed kinetic studies of the enzyme because the different pyridoxal phosphate-bound intermediates can be followed by their characteristic absorption spectra. We conducted a rapid reaction kinetic analysis of the full-length yeast enzyme in the forward and reverse directions. In the forward direction, we observed formation of the external aldimine of serine (14 mM-1 s-1) and the aminoacrylate intermediate (15 s-1). Homocysteine binds to the aminoacrylate with a bimolecular rate constant of 35 mM-1 s-1 and rapidly converts to cystathionine (180 s-1), leading to the accumulation of a 420 nm absorbing species, which has been assigned as the external aldimine of cystathionine. Release of cystathionine is slow (k = 2.3 s-1), which is similar to kcat (1.7 s-1) at 15 °C, consistent with this being a rate-determining step. In the reverse direction, cystathionine binds to the enzyme with a bimolecular rate constant of 1.5 mM-1 s-1 and is rapidly converted to the aminoacrylate without accumulation of the external aldimine. The kinetic behavior of the full-length enzyme shows notable differences from that reported for a truncated form of the enzyme lacking the C-terminal third of the protein (Jhee, K. H., Niks, D., McPhie, P., Dunn, M. F., and Miles, E. W. (2001) Biochemistry 40, 10873-10880).

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In mammals, cystathionine beta -synthase catalyzes the first step in the "reverse" trans-sulfuration pathway that converts the essential amino acid, methionine, to cysteine. In addition, it plays a key role in regulating the intracellular concentrations of homocysteine, a sulfur-containing amino acid that is correlated with a number of diseases at elevated levels including neural tube defects, cardiovascular diseases, and Alzheimer's disease (1-3). Mutations in cystathionine beta -synthase are the single most common cause of severe hyperhomocysteinemia, and approximately half of the patients are pyridoxine-responsive, i.e. they benefit from treatment with high doses of the vitamin B6 precursor, pyridoxine (4). Thus far, >90 different mutations have been described in the cystathionine beta -synthase gene in homocystinuric patients, with the vast majority being missense and private mutations (5). Cystathionine beta -synthase catalyzes the condensation of serine and homocysteine to give cystathionine in a pyridoxal phosphate (PLP)1-dependent reaction. Cystathionine is subsequently cleaved in the trans-sulfuration pathway by another PLP-dependent enzyme, gamma -cystathionase, to give cysteine and alpha -ketoglutarate.

Cystathionine beta -synthases from Trypanosoma cruzi, Saccharomyces cerevisiae, and humans have highly homologous sequences. All are predicted to belong to the beta  or Fold II family of PLP-dependent enzymes (6, 7). This similarity is borne out in the three-dimensional structure of the catalytic PLP-containing core of the enzyme, which has been reported recently (8), and resembles those of related PLP enzymes, viz. O-acetyl serine sulfhydrylase (9) and threonine deaminase (10). A major difference between the lower and higher eukaryotic cystathionine beta -synthases that have been characterized so far is the presence of a second cofactor, iron protoporphyrin IX (11), in the mammalian enzymes, which has unusual spectroscopic properties (12-15). The binding site for the heme is located in a 66-amino acid-long N-terminal extension that is missing in the yeast enzyme (8, 16). The heme is distant from the PLP, which is bound in the active site, and appears to play a regulatory role. In addition, S-adenosylmethionine serves as an allosteric effector of the mammalian but not the yeast enzyme, and binds to the C-terminal region of the protein (17).

The full-length yeast and human enzymes appear to exist in multiple oligomeric states as suggested by their broad elution profiles on gel filtration columns and their range from tetramer to octamer (13, 18). A hypersensitive proteolysis site results in the facile generation of a truncated species, the catalytic core, which exists as a dimer (18, 19). The dimeric human and yeast forms display high levels of enzyme activity and differences in their steady-state kinetic properties versus the corresponding full-length enzymes. A pre-steady-state kinetic characterization of the truncated form of the yeast enzyme has been reported recently (20). The truncated human enzyme retains its heme but loses sensitivity to regulation by S-adenosylmethionine (19). Although the reaction catalyzed by cystathionine beta -synthase superficially resembles those catalyzed by other PLP-dependent beta -replacement enzymes such as tryptophan synthase and O-acetyl serine sulfhydrylase, mechanistic and kinetic studies with potential suicide inactivators on the rat enzyme, reported by Borcsok and Abeles (21), have suggested some notable differences (21).

In general, rapid reaction kinetic analyses of PLP-dependent enzymes provide a rich source of information on the identity of catalytic intermediates. However, the presence of heme in the human enzyme dwarfs the spectroscopic signatures associated with the PLP species and renders these measurements difficult. As a first step toward identifying the intermediates in the reaction catalyzed by cystathionine beta -synthase, we used rapid reaction kinetics to characterize the full-length tetrameric form of the yeast enzyme as both a model and a guide for future studies on the human enzyme. We report a number of significant differences in the kinetics of the full-length yeast enzyme compared with that of the truncated form, engineered by deletion of C-terminal residues 354-507, which was reported recently (20).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Serine, D,L-homocysteine, and L-cystathionine were purchased from Sigma. The concentration of homocysteine was determined spectrophotometrically using Ellman's reagent (22).

Purification and Steady-state Kinetic Analysis of Yeast Cystathionine beta -Synthase-- Full-length yeast cystathionine beta -synthase was purified as described previously using a recombinant expression vector, pSEC (23), provided by Dr. Edith Miles (National Institutes of Health, Bethesda, MD). The activity of the enzyme and the steady-state kinetic parameters were measured in the radioactive assay as described previously (13). To determine the effects of preincubation with either serine or homocysteine, the enzyme was mixed with the first substrate for 5 min at 37 °C before being exposed to the second substrate, and the reaction was allowed to proceed for 30 min. For determination of substrate Km values, the concentration of the second substrate was fixed at 30 mM, whereas that of the first was varied.

Rapid Reaction Kinetics-- Stopped flow experiments were performed on an Applied Photophysics spectrophotometer (SX.MV18) equipped with a photodiode array detector. The temperature of the mixing chamber was maintained at 15 ± 1 °C and was controlled by a circulating water bath. A solution containing yeast cystathionine beta -synthase (18 µM) in 0.2 mM Tris buffer, pH 8, was mixed with varying concentrations of substrate in the same buffer, as indicated in the figure legends. When the reaction of preformed aminoacrylate with homocysteine was monitored, 18 µM enzyme was premixed with 30 mM serine in 0.2 M Tris, pH 8.0, and mixed rapidly with varying concentrations of homocysteine. Because of the limited solubility of cystathionine, a stock solution (0.5 M) was made in 0.8 N NaOH, and aliquots of this solution were diluted to give the desired concentration in 0.2 M Tris buffer, pH 8. The concentrations of enzyme and substrate refer to those before mixing; both solutions were diluted 2-fold after mixing. The reactions were followed with a photo-diode array detector.

Typically, time-dependent spectra were analyzed by the single value decomposition algorithm which is an integral feature of Pro-K program (Global Analysis for Spectra, Kinetic Data, version 4.20) supplied by Applied Photophysics. A set of output matrices comprising ordered sets of basis spectra and time-dependent amplitudes was obtained together with corresponding weighting factors known as singular values. The number of significant singular values is a model-free indication of the number of independent components present in the original data set. A kinetic model was built based on the number of independent spectra predicted by this method. The reported rate constants are the average of at least two different rapid mixing experiments. The spectra (recorded between 300 and 600 nm and between 1.3 and 500 ms), each containing 57,200 data points, were fit to Equation 1,
<UP>OD</UP>=<UP>C</UP> · e<SUP>−k · t</SUP> (Eq. 1)
where C is the amplitude, k is the rate constant, and OD, the optical density, is the sum of the absorbance of the individual species (lambda i) contributing to a given spectrum, each of which is described by Equation 2.
<UP>OD</UP>(&lgr;<SUB>i</SUB>)=<UP>C</UP>(&lgr;<SUB>i</SUB>) · e<SUP>−k(&lgr;i) · t</SUP> (Eq. 2)


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Steady-state Kinetic Analysis of Full Length Yeast Cystathionine beta -Synthase-- The kinetic parameters, Vmax and Km, for the yeast cystathionine beta -synthase under steady-state conditions are presented in Table I and are comparable with those reported previously (18). Unlike the human enzyme, the activity of the yeast enzyme is unaffected by whether it is preincubated with serine or homocysteine. The yeast cystathionine beta -synthase displays a bell-shaped dependence on pH with an optimum at 8.1 and inflection points corresponding to pKa values of 7.7 ± 0.1 and 8.8 ± 0.1, respectively (data not shown).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Summary of steady-state kinetic parameters for full-length yeast cystathionine beta -synthase determined under serine or homocysteine preincubation conditions

Reaction of Cystathionine beta -Synthase with Serine-- Absorbance changes resulting from rapid mixing of cystathionine beta -synthase with serine are shown in Fig. 1A. Global analysis of the spectrum (Fig. 1B) indicated the presence of three species assigned as the internal aldimine (lambda max = 412 nm), the external aldimine (lambda max = 416 nm), and the aminoacrylate (lambda max = 460 nm). There was no evidence for a gem-diamine (with a lambda max = 320 nm) at high serine concentrations or for a tautomeric form of the aminoacrylate (with a lambda max approx  320 nm) at low serine concentration as reported for the truncated yeast cystathionine beta -synthase (20). Formation of the external aldimine was linearly dependent on the concentration of serine (Fig. 1C) and yielded a bimolecular rate constant of 14 mM-1 s-1 and a Kd for serine of 1.5 ± 0.3 mM. Formation of the aminoacrylate showed saturation dependence on the concentration of serine and a maximal rate constant of 15 ± 0.4 s-1. For comparison, the kcat for yeast cystathionine beta -synthase at 15 °C is 1.7 s-1 calculated per mole of monomer of 56 kDa molecular mass.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Spectral changes resulting from the addition of serine to the cystathionine beta -synthase. Enzyme (18 µM) was mixed with varying concentrations of serine in 0.2 M Tris, pH 8.0. A, absorption changes seen between 1.3 and 500 ms after mixing 1.5 mM serine with enzyme are shown. The resting enzyme has an absorption maximum at 412 nm (internal aldimine) that is converted to a species with an absorption maximum at 460 nm, assigned as the aminoacrylate. B, global fitting of the time-dependent spectra in A reveals the presence of three species with absorption maxima at 412 (a), 416 (b), and 460 nm (c), respectively. C, dependence of the apparent rates of formation of the external aldimine (black-down-triangle ) and the aminoacrylate (open circle ) on the concentration of serine.

Reaction of E·Aminoacrylate with Homocysteine-- Kinetics of the second half reaction, i.e. addition of homocysteine to the aminoacrylate intermediate to form cystathionine, was followed by preincubating 18 µM enzyme with 30 mM serine to preform the aminoacrylate, which was then rapidly mixed with varying concentrations (0-60 µM) of D,L-homocysteine. At low concentrations of homocysteine, a decrease in the absorbance of the aminoacrylate intermediate is observed at 460 nm with a concomitant blue shift in the spectrum (Fig. 2A). In contrast, the disappearance of the preformed aminoacrylate with the truncated yeast cystathionine beta -synthase was reported to be too fast to measure even at low homocysteine concentration (20). However, at high concentrations of homocysteine, the decay of the aminoacrylate is completely missed (Fig. 2B), indicating that the reaction is rapid and largely over within the dead time of the instrument (2.2 ms). Instead, a rapid decrease at 420 nm, with a kobsd of 180 ± 5 s-1, is observed followed by a slow increase in absorption at the same wavelength with a rate constant of 0.7 s-1 (Fig. 2C). The species at 420 nm is tentatively assigned as the external aldimine of cystathionine, and its rate of formation is identical to the rate of disappearance of the 460 nm aminoacrylate at low concentrations of homocysteine (Fig. 2D). The nature of the change leading to an increase in the extinction coefficient of the 420 nm-absorbing species at a rate of 0.7 s-1 is not understood, and it is too slow to be catalytically relevant.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Spectral changes resulting from the addition of homocysteine to preformed aminoacrylate. Cystathionine beta -synthase (18 µM) was premixed with 30 mM serine and varying concentrations of homocysteine in 0.2 M Tris, pH 8.0. A, spectral changes observed between 1.3 and 500 ms after the addition of 0.15 mM D,L-homocysteine. B, spectral changes observed between 1.3 and 500 ms after the addition of 60 mM D,L-homocysteine. C, kinetics of absorption changes at 420 nm in the presence of 1 mM D,L-homocysteine. A rapid decline in the absorption occurs at a rate of 180 s-1 followed by a slow increase at a rate of 0.7 s-1. D, dependence of the apparent rate of disappearance of the aminoacrylate (lambda max = 460 nm) (black-down-triangle ) and the formation of the 420 nm-absorbing external aldimine of cystathionine (open circle ) on the concentration of homocysteine (after mixing). At high concentrations of homocysteine, the disappearance of the 460 nm species is too fast to be measured.

The dependence of the rate of disappearance of the aminoacrylate on the concentration of homocysteine yields a bimolecular rate constant of 35 ± 0.6 mM-1 s-1 and a Kd for homocysteine of 0.68 ± 0.03 mM (Fig. 2D).

Reaction of Enzyme with Cystathionine-- Rapid mixing of enzyme with cystathionine resulted in conversion of the external aldimine (lambda max = 412 nm) to the aminoacrylate with a lambda max of 460 nm (Fig. 3A). A clean isosbestic point is observed at 426 nm, indicating that an intermediate such as the external aldimine of cystathionine does not accumulate to detectable levels. Hence, the complexes between enzyme and cystathionine formed in the forward and reverse directions appear to be different. When equimolar serine and homocysteine are mixed with enzyme, the spectrum of the enzyme (lambda max = 420 nm) is consistent with the presence of the external aldimine of cystathionine (Fig. 2B), for which release is slow and presumably limits the overall reaction. In contrast, when the enzyme is mixed with cystathionine, the external aldimine is not detected, and the aminoacrylate form accumulates (Fig. 3A). The dependence of the rate of aminoacrylate formation on the concentration of cystathionine yields a bimolecular rate constant of 1.5 ± 0.1 mM-1 s-1 and a Kd for cystathionine of 1.6 ± 0.3 mM (Fig. 3B). The limited solubility of cystathionine precluded measurements at concentrations above 15 mM.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 3.   Spectral changes resulting from the addition of cystathionine to cystathionine beta -synthase. Enzyme (18 µM) in 0.2 M Tris, pH 8.0, was mixed with varying concentrations of L-cystathionine in the same buffer. A, spectral changes observed between 2.5 and 1000 ms after addition of 30 mM cystathionine. Conversion of the 412 nm resting enzyme spectrum to a 460-nm aminoacrylate species is observed with an isosbestic point at 426 nm. B, dependence of the apparent rate for formation of the aminoacrylate species on the concentration of cystathionine.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Differences in the spectroscopic signatures associated with the bound intermediates in PLP-dependent enzymes provide a convenient means for analyzing the kinetics of their formation and decay. Steady-state kinetic analysis of the yeast cystathionine beta -synthase indicates that it catalyzes a ping-pong reaction in which serine binds to generate an enzyme-bound aminoacrylate intermediate that reacts with homocysteine to give cystathionine (18). In this study, we report a pre-steady-state kinetic analysis of the reaction catalyzed by the full-length yeast cystathionine beta -synthase and note several differences between the behavior of this enzyme versus that of a truncated form that was reported earlier (20). The C-terminal amino acids from positions 354 to 507 were deleted in the truncated form, which resulted in a change in the oligomerization state from octameric to dimeric and an increase in the catalytic efficiency of the enzyme (18). Similar changes accompany deletion of the C-terminal 143 amino acids in the human enzyme (19).

The binary reaction of serine with enzyme to form the aminoacrylate proceeds via a detectable intermediate, the external aldimine (Scheme I). The observed rates of formation of the external aldimine and the aminoacrylate show a linear and hyperbolic dependence respectively on serine concentration (Fig. 1C). The Kd for serine obtained from this analysis is 1.5 ± 0.3 mM, which is slightly lower than that reported for the truncated enzyme (4.6 ± 0.8 mM). The rate of aminoacrylate formation is 14 ± 0.5 s-1, which is 8-fold greater than kcat but slower than the rate of aminoacrylate formation in the reverse direction from cystathionine (Scheme II). Formation of the aminoacrylate in the forward direction involves elimination of a poor leaving group (OH-) from the substrate, and would require enzyme assisted protonation (Scheme I). In contrast, formation of the aminoacrylate from cystathionine in the reverse reaction involves elimination of a better leaving group (thiolate) and may explain the difference in the rates (Scheme II).


View larger version (20K):
[in this window]
[in a new window]
 
Scheme I.   Intermediates in the reaction catalyzed by cystathionine beta -synthase and their absorption maxima as determined in this study. The two gem-diamine intermediates (GD-I and GD-II), shown in square brackets, were not observed in the pre-steady-state kinetic analysis of the full-length yeast enzyme. AA and Cyst denote aminoacrylate and cystathionine, respectively.


View larger version (17K):
[in this window]
[in a new window]
 
Scheme II.   Minimal kinetic scheme for reaction catalyzed by yeast cystathionine beta -synthase in the forward and reverse directions. The values shown in parentheses in A are taken from B, where the reaction was followed in the reverse direction.

In the truncated enzyme, the external aldimine of serine was not observed, and the kobsd reported for aminoacrylate formation (177 s-1) is comparable with the rate we observe for the disappearance of the internal aldimine at high serine concentration (~200 s-1, Fig. 1C). The observation of the external aldimine intermediate with the full-length enzyme allows deconvolution of the kobsd into bi- and unimolecular rate constants as shown in Fig. 1C.

The second-half reaction, i.e. conversion of the aminoacrylate to cystathionine, can be monitored by mixing preformed aminoacrylate with homocysteine. The disappearance of the aminoacrylate can be monitored at low but not high concentrations of homocysteine, where the reaction is over in the dead time of the instrument. The product of this reaction has an absorption maximum at 420 nm and is assigned as the external aldimine of cystathionine. The rate constant for the decrease in absorbance at 420 nm (180 ± 5 s-1) parallels the rate constant for the disappearance of the aminoacrylate at low homocysteine concentrations where the rate can be measured (Fig. 2D). The initial decrease (rather than increase) in absorbance at this wavelength may be due to the difference in the extinction coefficients of the aminoacrylate and the external aldimine at 420 nm. This is followed by a slow (0.7 s-1) and a low amplitude increase in absorption at the same wavelength, the basis of which is not known. This increase could result from a conformational change in the protein that leads to a change in the extinction coefficient of the external aldimine.

The reaction of cystathionine and enzyme to form an aminoacrylate species shows monophasic kinetics, and formation of an external aldimine intermediate is not observed (Fig. 3A). The observed rate constant for aminoacrylate formation in the reverse direction shows a hyperbolic dependence on cystathionine concentration and yields a Kd of 1.6 ± 0.3 mM, which is lower than the Kd reported for the truncated enzyme (7.45 ± 0.8 mM) (20). As noted previously, this enzyme exhibits substrate inhibition with homocysteine, and the reaction of cystathionine with enzyme is not a simple reversal of the forward reaction, i.e. the reaction of preformed aminoacrylate with homocysteine (20).

The accumulation of the 420 nm species in the forward direction assigned as the external aldimine of cystathionine (Fig. 2B) indicates that product release is rate-limiting, a conclusion that was also reached with the truncated enzyme (20). Based on the kinetics of the reverse reaction, the rate of cystathionine release from the enzyme is 2.3 s-1, which is similar to kcat (1.7 s-1) and is consistent with this being a rate-determining step (Scheme II).

In summary, notable differences are observed in the pre-steady-state kinetic analysis of intermediates in the reactions catalyzed by full-length and truncated yeast cystathionine beta -synthase. A gem-diamine intermediate is seen in the presence of serine with the truncated but not full-length enzyme, whereas the external aldimine of serine is observed with full-length but not truncated enzyme. Similarly, a 320 nm absorbance assigned as the gem-diamine of cystathionine is observed when the aminoacrylate is mixed with homocysteine in the truncated but not the full-length enzyme. Quinonoid intermediates are not seen with either enzyme form, which is similar to the reaction catalyzed by the closely related PLP-dependent enzyme, O-acetyl serine sulfhydralase (24). This has been rationalized by Cook and co-workers (9) to result from the mismatch in the pKa values of the N1 of PLP and Ser-272, making protonation of N1 unlikely and thereby disfavoring quinonoid formation. A homologous serine is conserved in both yeast and human cystathionine beta -synthase (25). The studies with the full-length yeast enzyme should be useful in elucidating the kinetic mechanism of the human enzyme.

    FOOTNOTES

* This work was supported by Grant HL58984 from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger An Established Investigator of the American Heart Association. To whom correspondence should be addressed. Tel.: 402-472-2941; E-mail: rbanerjee1@unl.edu.

Published, JBC Papers in Press, April 10, 2002, DOI 10.1074/jbc.M202513200

    ABBREVIATIONS

The abbreviation used is: PLP, pyridoxal phosphate.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Refsum, H., Ueland, P. M., Nygard, O., and Vollset, S. E. (1998) Annu. Rev. Med. 49, 31-62[CrossRef][Medline] [Order article via Infotrieve]
2. Mills, J. L., McPartlin, J. M., Kirke, P. N., Lee, Y. J., Conle, M. R., and Weir, D. G. (1995) Lancet 345, 149-151[CrossRef][Medline] [Order article via Infotrieve]
3. Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., and Ueland, P. M. (1998) Arch. Neurol. 55, 1449-1455[Abstract/Free Full Text]
4. Mudd, S. H., Skovby, F., Levy, H. L., Pettigrew, K. D., Wilcken, B., Pyeritz, R. E., Andria, G., Boers, G. H., Bromberg, I. L., Cerone, R., et al.. (1985) Am. J. Hum. Genet. 37, 1-31[Medline] [Order article via Infotrieve]
5. Kraus, J. P., Janosik, M., Kozich, V., Mandell, R., Shih, V., Sperandeo, M. P., Sebastio, G., de Franchis, R., Andria, G., Kluijtmans, L. A., Blom, H., Boers, G. H., Gordon, R. B., Kamoun, P., Tsai, M. Y., Kruger, W. D., Koch, H. G., Ohura, T., and Gaustadnes, M. (1999) Hum. Mutat. 13, 362-375[CrossRef][Medline] [Order article via Infotrieve]
6. Alexander, F. W., Sandmeier, E., Mehta, P. K., and Christen, P. (1994) Eur. J. Biochem. 219, 953-960[Medline] [Order article via Infotrieve]
7. Grishin, N. V., Phillips, M. A., and Goldsmith, E. J. (1995) Protein Sci. 4, 1291-1304[Abstract]
8. Meier, M., Janosik, M., Kery, V., Kraus, J. P., and Burkhard, P. (2001) EMBO J. 20, 3910-3916[CrossRef][Medline] [Order article via Infotrieve]
9. Burkhard, P., Rao, G. S., Hohenester, E., Schnackerz, K. D., Cook, P. F., and Jansonius, J. N. (1998) J. Mol. Biol. 283, 121-133[CrossRef][Medline] [Order article via Infotrieve]
10. Gallagher, D. T., Gilliland, G. L., Xiao, G., Zondlo, J., Fisher, K. E., Chinchilla, D., and Eisenstein, E. (1998) Structure 6, 465-475[Medline] [Order article via Infotrieve]
11. Kery, V., Bukovska, G., and Kraus, J. P. (1994) J. Biol. Chem. 269, 25283-25288[Abstract/Free Full Text]
12. Taoka, S., Green, E. L., Loehr, T. M., and Banerjee, R. (2001) J. Inorg. Biochem. 87, 253-259[CrossRef][Medline] [Order article via Infotrieve]
13. Taoka, S., Ohja, S., Shan, X., Kruger, W. D., and Banerjee, R. (1998) J. Biol. Chem. 273, 25179-25184[Abstract/Free Full Text]
14. Taoka, S., and Banerjee, R. (2001) J. Inorg. Biochem. 87, 245-251[CrossRef][Medline] [Order article via Infotrieve]
15. Ojha, S., Hwang, J., Kabil, O., Penner-Hahn, J. E., and Banerjee, R. (2000) Biochemistry 39, 10542-10547[CrossRef][Medline] [Order article via Infotrieve]
16. Ojha, S., Wu, J., LoBrutto, R., and Banerjee, R. (2002) Biochemistry 41, 4649-4654[CrossRef][Medline] [Order article via Infotrieve]
17. Finkelstein, J. D., Kyle, W. E., Martin, J. J., and Pick, A.-M. (1975) Biochem. Biophys. Res. Commun. 66, 81-87[CrossRef][Medline] [Order article via Infotrieve]
18. Jhee, K. H., McPhie, P., and Miles, E. W. (2000) Biochemistry 39, 10548-10556[CrossRef][Medline] [Order article via Infotrieve]
19. Taoka, S., Widjaja, L., and Banerjee, R. (1999) Biochemistry 38, 13155-13161[CrossRef][Medline] [Order article via Infotrieve]
20. Jhee, K. H., Niks, D., McPhie, P., Dunn, M. F., and Miles, E. W. (2001) Biochemistry 40, 10873-10880[CrossRef][Medline] [Order article via Infotrieve]
21. Borcsok, E., and Abeles, R. H. (1982) Arch. Biochem. Biophys. 213, 695-707[CrossRef][Medline] [Order article via Infotrieve]
22. Ellman, G. L. (1959) Arch. Biochem. Biophys. 82, 70-77[CrossRef][Medline] [Order article via Infotrieve]
23. Jhee, K. H., McPhie, P., and Miles, E. W. (2000) J. Biol. Chem. 275, 11541-11544[Abstract/Free Full Text]
24. Tai, C.-H., and Cook, P. F. (2001) Acc. Chem. Res. 34, 49-59[CrossRef][Medline] [Order article via Infotrieve]
25. Kabil, Ö., Taoka, S., LoBrutto, R., Shoemaker, R., and Banerjee, R. (2001) J. Biol. Chem. 276, 19350-19355[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. W. Miles and J. P. Kraus
Cystathionine {beta}-Synthase: Structure, Function, Regulation, and Location of Homocystinuria-causing Mutations
J. Biol. Chem., July 16, 2004; 279(29): 29871 - 29874.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Oliveriusova, V. Kery, K. N. Maclean, and J. P. Kraus
Deletion Mutagenesis of Human Cystathionine beta -Synthase. IMPACT ON ACTIVITY, OLIGOMERIC STATUS, AND S-ADENOSYLMETHIONINE REGULATION
J. Biol. Chem., December 6, 2002; 277(50): 48386 - 48394.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/25/22421    most recent
M202513200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taoka, S.
Right arrow Articles by Banerjee, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taoka, S.
Right arrow Articles by Banerjee, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.